In clinical practice, fecal microbiota transplantation (FMT) has been used to treat
inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of …

Increasingly studies revealed that dysbiosis of gut microbiota plays a pivotal role in the
pathogenesis of ulcerative colitis (UC). Fecal microbiota transplantation (FMT) has drawn …

BACKGROUND Emerging evidence has demonstrated that fecal microbiota transplantation
(FMT) has a promising therapeutic effect on mice with experimental colitis and patients with …

Restoring intestinal microbiota dysbiosis with fecal microbiota transplantation is considered
as a promising treatment for ulcerative colitis. However, the mechanisms underlying its …

Ulcerative colitis (UC) is a chronic non-specific inflammatory disease that occurs in the colon
and rectum. While fecal microbiota transplantation (FMT) is gaining attention as a clinical …

Ulcerative colitis (UC) is a chronic inflammatory disease of the intestine. It is characterized
with recurrent. The pathogenesis is mainly associated with environmental factors, genetic …

Inflammatory bowel disease (IBD) is an increasing global burden and a predisposing factor
to colorectal cancer. Although a number of treatment options are available, the side effects …

BACKGROUND Fecal microbiota transplantation (FMT) has shown promising therapeutic
effects on mice with experimental colitis and patients with ulcerative colitis (UC). FMT …

Background and Aims Ulcerative colitis (UC) has become a global public health concern,
and is in urgent need of novel therapies. Fecal microbiota transplantation (FMT) targeting …

Background Ulcerative colitis (UC) is a chronic condition and the most common form of
inflammatory bowel disease. The goal of standard treatment is mainly to induce and …